Institutional Capacity and Practices for Maternal Anemia in China

In China, a range of anemia prevention and treatment measures have been developed and implemented in recent decades. These measures provide a regulatory basis for implementing standardized maternal anemia prevention and treatment services in China. However, little is known about the adoption of these interventions by health professionals, the capacity of health facilities to screen for iron deficiency and anemia, or the level of compliance among pregnant and lactating women (PLW). Thus, this study explored the alignment between maternal anemia prevention and control services provided and generated evidence for potential policy and program revisions and updates. A cross-sectional survey was conducted between November 2019 and January 2020. A total of 11 counties from 6 provinces across eastern, central and western regions of China were selected for the survey. In the surveyed sites, a total of 42 health institutions were enrolled in the survey, and a total of 201 health providers and 1714 PLW were enrolled in the suervey and completed the questionnaires. The results of this study showed that iron supplements containing 30 and 60 mg of iron were available in one third of the health facilities surveyed. All obstetricians reported ordering the Hb test for pregnant women receiving antenatal care (ANC) services, and 87.6% ordered the ferritin test. The proportion of obstetricians who ordered the ferritin test at the township level facilities (79.4%) was significantly lower than that at the provincial (100%), prefectural (87.5%) and county (87.1%) level facilities (p < 0.05). Around 89.6% and 90.5% of obstetricians prescribed iron to pregnant women when they were diagnosed with anemia and ID, respectively. 41.3% of obstetricians advised women to take preventive iron throughout their pregnancy. The proportion of obstetricians from township level hospitals that advised women to take preventative iron throughout their pregnancy (61.5%) was significantly lower than that from provincial facilities (23.5%) (p < 0.05). A total of 95.2% and 47.9% of PLW reported receiving the Hb test and the serum ferritin test during their pregnancy, respectively. There are some barriers and bottlenecks in the effective implementation of anemia intervention measures for pregnant women in China. Therefore, to achieve international and national targets on further reducing maternal anemia prevalence, comprehensive actions need to be taken.